617 related articles for article (PubMed ID: 30452072)
1. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats.
Kamble SH; Berthold EC; King TI; Raju Kanumuri SR; Popa R; Herting JR; León F; Sharma A; McMahon LR; Avery BA; McCurdy CR
J Nat Prod; 2021 Apr; 84(4):1104-1112. PubMed ID: 33620222
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry.
Sharma A; Kamble SH; León F; Chear NJ; King TI; Berthold EC; Ramanathan S; McCurdy CR; Avery BA
Drug Test Anal; 2019 Aug; 11(8):1162-1171. PubMed ID: 30997725
[TBL] [Abstract][Full Text] [Related]
4. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
Fowble KL; Musah RA
Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review.
Ya K; Tangamornsuksan W; Scholfield CN; Methaneethorn J; Lohitnavy M
Asian J Psychiatr; 2019 Jun; 43():73-82. PubMed ID: 31100603
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mitragynine in man.
Trakulsrichai S; Sathirakul K; Auparakkitanon S; Krongvorakul J; Sueajai J; Noumjad N; Sukasem C; Wananukul W
Drug Des Devel Ther; 2015; 9():2421-9. PubMed ID: 25995615
[TBL] [Abstract][Full Text] [Related]
8. Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method.
Berthold EC; Kamble SH; Raju KS; King TI; Popa R; Sharma A; León F; Avery BA; McMahon LR; McCurdy CR
J Pharm Biomed Anal; 2021 Feb; 194():113778. PubMed ID: 33277117
[TBL] [Abstract][Full Text] [Related]
9. Accelerated Solvent Extractions (ASE) of
Goh YS; Karunakaran T; Murugaiyah V; Santhanam R; Abu Bakar MH; Ramanathan S
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204457
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics and Safety of Mitragynine in Beagle Dogs.
Maxwell EA; King TI; Kamble SH; Raju KSR; Berthold EC; León F; Avery BA; McMahon LR; McCurdy CR; Sharma A
Planta Med; 2020 Nov; 86(17):1278-1285. PubMed ID: 32693425
[TBL] [Abstract][Full Text] [Related]
11. The effects of chronic mitragynine (Kratom) exposure on the EEG in rats.
Suhaimi FW; Hassan Z; Mansor SM; Müller CP
Neurosci Lett; 2021 Feb; 745():135632. PubMed ID: 33444671
[TBL] [Abstract][Full Text] [Related]
12. The neuromuscular blockade produced by pure alkaloid, mitragynine and methanol extract of kratom leaves (Mitragyna speciosa Korth.).
Chittrakarn S; Keawpradub N; Sawangjaroen K; Kansenalak S; Janchawee B
J Ethnopharmacol; 2010 Jun; 129(3):344-9. PubMed ID: 20371282
[TBL] [Abstract][Full Text] [Related]
13. Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats.
Sabetghadam A; Ramanathan S; Sasidharan S; Mansor SM
J Ethnopharmacol; 2013 Apr; 146(3):815-23. PubMed ID: 23422336
[TBL] [Abstract][Full Text] [Related]
14. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: present knowledge and future directions in perspective of pain.
Ramachandram DS; Damodaran T; Zainal H; Murugaiyah V; Ramanathan S
J Basic Clin Physiol Pharmacol; 2019 Oct; 31(1):. PubMed ID: 31665120
[TBL] [Abstract][Full Text] [Related]
16. Lateral Flow Assessment and Unanticipated Toxicity of Kratom.
Smith LC; Lin L; Hwang CS; Zhou B; Kubitz DM; Wang H; Janda KD
Chem Res Toxicol; 2019 Jan; 32(1):113-121. PubMed ID: 30380840
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia.
Singh D; Müller CP; Murugaiyah V; Hamid SBS; Vicknasingam BK; Avery B; Chear NJY; Mansor SM
J Ethnopharmacol; 2018 Mar; 214():197-206. PubMed ID: 29248450
[TBL] [Abstract][Full Text] [Related]
18. Oral Pharmacokinetics in Beagle Dogs of the Mitragynine Metabolite, 7-Hydroxymitragynine.
Maxwell EA; King TI; Kamble SH; Raju KSR; Berthold EC; León F; Hampson A; McMahon LR; McCurdy CR; Sharma A
Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):459-463. PubMed ID: 33847897
[TBL] [Abstract][Full Text] [Related]
19. Respiratory effects of oral mitragynine and oxycodone in a rodent model.
Henningfield JE; Rodricks JV; Magnuson AM; Huestis MA
Psychopharmacology (Berl); 2022 Dec; 239(12):3793-3804. PubMed ID: 36308562
[TBL] [Abstract][Full Text] [Related]
20. Phase I and II metabolites of speciogynine, a diastereomer of the main Kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry.
Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
J Mass Spectrom; 2010 Nov; 45(11):1344-57. PubMed ID: 20967737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
